´ëÇѽɺÎÀüÇÐȸ Á¦43Â÷ Ãß°è Çмú´ëȸ(Heart Failure Seoul 2021) 1ÀÏÂ÷ : 2021-09-16±³À°ÀÏÀÚ : 2021-09-16
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5Ãþ ±×·£µåº¼·ë
±³À°ÁÖÁ¦ :
´ëÇѽɺÎÀüÇÐȸ Á¦43Â÷ Ãß°è Çмú´ëȸ(Heart Failure Seoul 2021) 1ÀÏÂ÷ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽɺÎÀüÇÐȸ
´ã´çÀÚ : ¹éÁöÀº
¿¬¶ôó : 02-3275-5335
À̸ÞÀÏ :
khfs4@khfs.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 2 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í ±³¼ö: 70,000¿ø, ÀϹÝÀÇ: 30,000¿ø, Àü°øÀÇ, °£È£»ç, 65¼¼ ÀÌ»ó, Çлý, ±âŸ(ÀÌ¿Ü ÀÇ·áÁ¾»çÀÚ): ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-16 ±×·£µåº¼·ë 15:20~15:40 Complex Interplay between HF and Cancer Javid Moslehi(Vanderbilt Univ. USA)
±³À°½Ã°£ 09-16 ±×·£µåº¼·ë 15:00~15:20 Risk Stratification and Prevention of Myocardial Dysfunction in Cancer Patients ±èÀº°æ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 09-16 ±×·£µåº¼·ë 15:40~16:00 Atrial Fibrillation during Chemotherapy: Risk and Benefit of Anticoagulation ȲÀÎâ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09-16 ±×·£µåº¼·ë 16:00~16:10 Multiple Myeloma and Cardiac Amyloidosis : Challenges of Management Thibaud Damy(University Hospital Henri Mondor France)
Åä·Ð 09-16 ±×·£µåº¼·ë 16:10~16:20 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 09-16 ±×·£µåº¼·ë 16:20~16:30 Short Coffee Break ()
±³À°½Ã°£ 09-16 ±×·£µåº¼·ë 16:30~16:45 Korean Perspective, Upcoming ESC HF Guidelines Á¶ÇöÀç(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09-16 ±×·£µåº¼·ë 16:45~17:00 What's New in HFrEF? Andrew Coats(HFA of the ESC)
±³À°½Ã°£ 09-16 ±×·£µåº¼·ë 17:00~17:15 What's New in HFpEF? Gerasimos Filippatos(HFA of the ESC)
±³À°½Ã°£ 09-16 ±×·£µåº¼·ë 17:15~17:30 Chronic or Acute HF? Or HF Continum À¯º´¼ö(¿¬¼¼¿øÁÖÀÇ´ë)
Åä·Ð 09-16 ±×·£µåº¼·ë 17:30~18:00 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)